Aura Biosciences FY 2023 EPS $(1.93) Misses $(1.82) Estimate
Aura Biosciences FY 2023 EPS $(1.93) Misses $(1.82) Estimate
Aura Biosciences 2023 財年每股收益 (1.93) 未達到預期 (1.82) 美元
Aura Biosciences (NASDAQ:AURA) reported quarterly losses of $(1.93) per share which missed the analyst consensus estimate of $(1.82) by 6.04 percent. This is a 1.53 percent increase over losses of $(1.96) per share from the same period last year.
Aura Biosciences（納斯達克股票代碼：AURA）公佈的季度虧損爲每股1.93美元，比分析師普遍預期的1.82美元（1.82美元）低6.04％。這比去年同期每股虧損1.96美元（1.96美元）增長了1.53％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。